Management of Acute Rhinitis (Running Nose + Sneezing) in a 50-Year-Old Male

Step-by-Step Management

1. History & Assessment

• Onset & triggers: Seasonal, perennial, or post-viral?
• Associated symptoms: Fever, sore throat, itchy eyes, nasal polyps history?
• Comorbidities: Asthma, hypertension (affects decongestant use), BPH (affects antihistamines)
• Medications: NSAIDs, ACE inhibitors (can cause rhinitis)

2. Pharmacological Management

First-Line: Intranasal Corticosteroids (INCS)

• Preferred monotherapy for persistent allergic rhinitis (Rhinitis Guidelines, p. 2)
• Examples: Fluticasone furoate, Mometasone furoate, Budesonide
• Onset: 12–24 hours; full effect in 1–2 weeks
• Safe for long-term use

Second-Line / Adjunct: Antihistamines

• Intranasal antihistamines (e.g., Azelastine): First-line option for non-allergic rhinitis (NAR); additive benefit when combined with INCS
• Oral 2nd-generation antihistamines (preferred in a 50-year-old to avoid sedation):
  • Cetirizine 10 mg OD
  • Loratadine 10 mg OD
  • Fexofenadine 120–180 mg OD
• Avoid 1st-generation antihistamines (sedation, anticholinergic side effects in older adults)

Intranasal Anticholinergic: Ipratropium Bromide

• Effective specifically for rhinorrhea (anterior type) (Rhinitis, p. 26)
• 0.03% concentration for perennial/non-allergic rhinitis
• No significant effect on sneezing or congestion — use as an add-on
• Side effects: Nasal dryness, epistaxis (usually mild)

Decongestants

• Oral pseudoephedrine: Useful for congestion; use with caution in a 50-year-old (hypertension, cardiac risk, BPH)
• Intranasal oxymetazoline: Short-term only (≤3–5 days) to prevent rebound congestion (rhinitis medicamentosa)
• Can be combined with INCS for up to 4 weeks in selected patients (Rhinitis Guidelines, p. 2)

Montelukast (Leukotriene antagonist)

• Not first-line — use only if inadequate response or intolerance to INCS/antihistamines (Rhinitis Guidelines, p. 2)

3. Non-Pharmacological Measures

• Saline nasal irrigation (isotonic or hypertonic) — helps clear secretions, safe, adjunctive
• Avoid triggers: Allergens, cold air, smoke, strong odors
• Steam inhalation — symptomatic relief for viral rhinitis
• Adequate hydration and rest if viral etiology

4. Algorithm Based on Duration & Likely Cause

3-day history → Likely acute/intermittent AR or viral rhinitis

If suspected ALLERGIC (sneezing, itching, known allergens):
  → 2nd-gen oral antihistamine + INCS
  → If no relief in 2 weeks → consider allergen testing / immunotherapy

If suspected NON-ALLERGIC / VIRAL:
  → INCS ± intranasal antihistamine
  → Ipratropium 0.03% if rhinorrhea dominant
  → Short-term intranasal decongestant if nasal congestion present

If symptoms persist >2–4 weeks → Re-evaluate for:
  → Chronic rhinitis, sinusitis, nasal polyps, structural causes

5. When to Refer / Investigate Further

• Symptoms >4 weeks (consider allergy testing — skin prick test / specific IgE)
• Unilateral nasal discharge (rule out foreign body, tumor)
• Blood-stained discharge
• Associated with facial pain, fever, purulent discharge (→ sinusitis)
• Poor response to treatment

Key Takeaways for a 50-Year-Old Male

• Avoid 1st-generation antihistamines (sedation, cognitive effects, urinary retention risk)
• Check BP before prescribing oral decongestants
• INCS are safe and effective and should be the backbone of therapy if symptoms suggest AR or are persisting beyond a few days